NCT04840953View on ClinicalTrials.gov

Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

February 1, 2021

Conditions

Subcutaneous EmphysemaCovid19

Interventions

DEVICE

Vçac

VAC THERAPY vs SURGICAL DREINAGE

Trial Locations (1)

03203

Hospital General Universitario de Elche, Elche

All Listed Sponsors

lead

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

OTHER

NCT04840953 - Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients | Biotech Hunter | Biotech Hunter